{
 "name": "巨生醫",
 "slug": "tw-6827",
 "aliases": [
  "巨生生醫股份有限公司",
  "MPB",
  "6827"
 ],
 "ticker": "6827",
 "industry": "生技醫療業",
 "website": "http://www.megaprobio.com",
 "summary": "巨生醫（6827）是興櫃的生技醫療類股公司，2014 年成立，2021 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "巨生生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "MPB",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2021-10-19",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2014-11-07",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "蔣為峰",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "許源宏",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 792935030,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "http://www.megaprobio.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：MPB-1523（IOP Injection）",
   "value": "肝臟局部病灶之MRI顯影診斷｜第III期IND已通過FDA30天審查，將啟動試驗｜美國",
   "unit": "",
   "as_of": "2026-10-09",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "IOP-CT-007；發言日期115/10/09 15:03:52，6827、序號1；主旨：本公司新藥MPB-1523 MRI顯影劑-肝細胞癌向美國FDA申請進行第三期臨床試驗(計畫編號:IOP-CT-007)，已通過美國FDA IND 30天審查期，將啟動MPB-1523三期臨床試驗。不是藥品上市核准，未稱已收案。"
  },
  {
   "claim": "管線：MPB-1514（IOP Injection）",
   "value": "缺鐵性貧血｜第II期已終止（歷史登錄；非成功完成）｜美國",
   "unit": "",
   "as_of": "2021-10-28",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT03485053",
   "note": "NCT03485053；ClinicalTrials.gov最後公開更新 2021-10-28；登錄狀態 TERMINATED。"
  },
  {
   "claim": "管線：MPB-2043",
   "value": "頭頸部鱗狀細胞癌淋巴結轉移分期之MRI影像｜第I期、登錄招募中（2025-05-08更新）｜台灣",
   "unit": "",
   "as_of": "2025-05-08",
   "source": "https://clinicaltrials.gov/api/v2/studies/NCT06540443",
   "note": "NCT06540443；ClinicalTrials.gov最後公開更新 2025-05-08；登錄狀態 RECRUITING。登錄估計2026-09完成日已過，未把日期當完成證據；公司2026-04-29簡報第16頁仍載收案中。"
  },
  {
   "claim": "管線：MPB-1734（cabazitaxel奈米微胞）",
   "value": "攝護腺癌之無Tween-80新劑型｜準備CMC及生體相等性（BE）試驗｜美國、台灣",
   "unit": "",
   "as_of": "2026-04-29",
   "source": "https://www.megaprobio.com/images/File/20260429_ju%20sheng%20fa%20shuo%20hui_EN.pdf",
   "note": "2026-04-29法說簡報第13-14、24頁；不是BE已完成或藥證已核准。"
  },
  {
   "claim": "催化劑：MPB-1734",
   "value": "BE試驗IND送件｜2026Q4（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-04-29",
   "source": "https://www.megaprobio.com/images/File/20260429_ju%20sheng%20fa%20shuo%20hui_EN.pdf",
   "note": "公司簡報第14頁；臨床/主管機關審查可能調整。"
  },
  {
   "claim": "管線：MPB-2354（RegenTrace）",
   "value": "無法選擇血管重建之嚴重肢體缺血（no-option CLI）｜準備第I期｜美國",
   "unit": "",
   "as_of": "2026-04-29",
   "source": "https://www.megaprobio.com/images/File/20260429_ju%20sheng%20fa%20shuo%20hui_EN.pdf",
   "note": "法說簡報第24頁表格：MPB-2354、No-option CLI、United States；非已開始人體試驗。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6827.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}